ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2020 American Transplant Congress

    Efficacy and Safety of Single-Dose Rabbit Anti-Thymocyte Globulin versus Basiliximab Induction among Pediatric Kidney Transplant Recipients

    L. Porini Custodio, S. Stopa Martins, L. Almeida Viana, M. Pontello Cristelli, M. Rika Nakamura, H. Tedesco-Silva, J. Medina-Pestana

    Hospital do Rim, Sao Paulo, Brazil

    *Purpose: Induction therapy is a standard component of kidney transplant immunosuppression protocols. However, in the pediatric population, there are still uncertainties about the ideal induction…
  • 2020 American Transplant Congress

    Pharmacokinetic Evaluation of a De Novo Envarsus XR® (tacrolimus Extended Release) Dosing Strategy in Kidney Transplant Recipients

    J. Schulte1, C. Kane1, K. Cunningham1, C. D'Agostino1, M. Kapugi1, A. Novak1, A. Shetty2, J. Leventhal2, J. Friedewald2

    1Department of Pharmacy, Northwestern Memorial Hospital, Chicago, IL, 2Division of Transplantation, Northwestern Memorial Hospital, Chicago, IL

    *Purpose: Envarsus XR® is a once-daily tablet formulation of tacrolimus recently approved for the prophylaxis of organ rejection in de novo kidney transplant recipients (KTx).…
  • 2020 American Transplant Congress

    Sleeve Gastrectomy Compared with Gastric Bypass for Morbidly Obese Liver Transplant Candidates: A Decision Analysis

    R. A. Choudhury1, D. Yoeli1, G. Hoeltzel2, H. B. Moore1, H. Yaffe1, K. R. Dumon3, N. N. Williams3, P. L. Abt4, K. D. Conzen1, J. J. Pomposelli1, E. A. Pomfret1, T. L. Nydam1

    1Department of Surgery- Division of Transplantation Surgery, University of Colorado Hospital, Aurora, CO, 2Thomas Jefferson University Hospital, Philadelphia, PA, 3Department of Surgery, University of Pennsylvania Hospital, Philadelphia, PA, 4Department of Surgery- Division of Transplantation Surgery, University of Pennsylvania Hospital, Philadelphia, PA

    *Purpose: The use of bariatric surgery has increased for morbidly obese liver transplant candidates for whom placement on the waitlist is often restricted until they…
  • 2020 American Transplant Congress

    Karnofsky Performance Status Significantly Increases Waitlist Mortality among Different Grades of Acute on Chronic Liver Failure

    A. Ashhab1, R. Wong2, V. Sundaram1

    1Cedars Sinai Medical Center, Los Angeles, CA, 2Alameida Health System, Oakland, CA

    *Purpose: Acute on chronic liver failure (ACLF) is a condition associated with high waitlist mortality and graded according to the number of organ system failures…
  • 2020 American Transplant Congress

    Induction Immunosuppression with Thymoglobulin May Improve Graft Outcomes without Increasing a Risk for Infection in Patients Undergoing Liver Transplantation Alone

    M. Henry1, T. Kitajima2, J. Konel1, S. Yeddula2, M. Rizzari2, K. Collins2, D. Moonka2, A. Yoshida2, M. Abouljoud2, S. Nagai3

    1Wayne State University School of Medicine, Detroit, MI, 2Henry Ford Hospital, Detroit, MI, 3Transplant and Hepatobiliary Surgery, Henry Ford Hospital, Detroit, MI

    *Purpose: Immunosuppression protocols for liver transplant (LT) vary between institutions and roles of induction immunosuppression in LT remain controversial. The aim of this study was…
  • 2020 American Transplant Congress

    Multimodal Strategy for Hepatocellular Carcinoma in the Elderly: To Transplant or Not to Transplant

    M. Najjar1, O. Perez1, J. Zou1, S. Sun1, K. Bruestle1, P. Jiang1, E. Verna1, E. Zheng1, Y. Saenger1, A. Mathur1, A. Griesemer1, B. Samstein2, T. Kato1, K. Halazun2, J. Emond1

    1Columbia University Irving Medical Center, New York, NY, 2Weill Cornell Medicine, New York, NY

    *Purpose: Liver transplantation LT for HCC is curative but entails increased risk and is limited by organ scarcity. Alternative approaches such as locoregional therapy (LRT)…
  • 2020 American Transplant Congress

    Different Prognostic Impact of Liver Transplantation According to Liver Disease Etiologies

    S. Nagai, T. Kitajima, S. Yeddula, D. Moonka, K. Collins, M. Rizzari, A. Yoshida, M. Abouljoud

    Henry Ford Hospital, Detroit, MI

    *Purpose: Disease specific background is not taken into consideration in the MELD-Na score based liver transplant (LT) allocation system. We hypothesized that optimal timing of…
  • 2020 American Transplant Congress

    Clinical and Laboratory Characteristics of Early and Late-Onset Cytomegalovirus Infection Following Universal Prophylaxis in Kidney Transplant Recipients

    M. M. Tavakol, B. Lee, S. Ashimine, H. Crossman, M. Park, Z. Laszik, J. Roberts

    University of California, San Francisco, San Francisco, CA

    *Purpose: Cytomegalovirus (CMV) is the most important viral infection in organ recipients and can cause life-threatening infections, compromising long-term graft function. Most transplant centers use…
  • 2020 American Transplant Congress

    Late Pneumocystis Jirovecii Pneumonia Often Misdiagnosed

    M. Samaniego1, R. Prashar1, N. Khoury2, A. Patel2

    1Transplant Institute, Henry Ford Health System, Detroit, MI, 2Transplant Institute, Henry Ford Health System, Ann Arbor, MI

    *Purpose: Since 2/2018, we have identified 60 transplant recipients presenting with late PCR confirmed Pneumocystis jirovecii (PJP). Of this initial group, 17 kidney transplant recipients…
  • 2020 American Transplant Congress

    The Economic Impact of HCV D+/R- Kidney Transplantation

    S. Meade1, M. A. Simpson2, E. D. Walshe1, M. E. Akoad2, F. D. Gordon2

    1Lahey Clinic, Burlington, MA, 2Transplantation, Lahey Clinic, Burlington, MA

    *Purpose: In September 2018, we began offering carefully screened kidney transplant candidates the opportunity for transplantation with kidneys from hepatitis C (HCV) positive deceased donors.…
  • « Previous Page
  • 1
  • …
  • 188
  • 189
  • 190
  • 191
  • 192
  • …
  • 223
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences